UC patents that paid off

Here is a look at some of UC’s most lucrative patented inventions and products. Revenues include licensing fees, royalties and stock sales over time.

Hepatitis B vaccine: $436 million

Human growth hormone: $245 million

Treatment of intracranial aneurysms: $152 million

Bovine growth hormone: $148 million

Prostate cancer drug: $111 million

Process for splicing genes: $108 million

Immune activator for treating cancer: $88 million

EGF receptor antibodies: $77 million

Interstitial cystitis therapy: $63 million

Dynamic skin cooling device: $49 million

Chromosome painting: $44 milion

Camarosa strawberry: $41 million

Numbers rounded to the nearest million.

Source: University of California